Abstract
Antibacterial strategies to eradicate superbugs from hospitals/nursing homes have had limited success, suggesting the need for employing innovative preventative measures and better understanding of the prevalence of microbial pathogens in close proximity of susceptible populations. A total of 120 environmental samples were collected from the Aga Khan University hospital. Amoebae were identified using morphological characteristics as well as PCR using genus-specific primers, while bacteria were identified using standard biochemical testing. Out of 120 samples tested, 52 (43.3 %) samples were positive for Acanthamoeba, while all 120 (100 %) samples were positive for bacteria. Following bacterial identification, samples showed mixed bacterial populations. Out of 120 samples, 76 (63.3 %) samples were positive for Bacillus spp., 64 (53.3 %) samples were positive for Corynebacterium spp., 32 (26.6 %) samples were positive for Staphylococcus spp., and 9 (7.5 %) samples were positive for Micrococcus spp. The antibiotic susceptibility showed that all bacterial isolates recovered were multiple drug-resistant. The current findings suggest that Acanthamoeba and bacteria coexist in a clinical environment. Given that Acanthamoeba can harbor bacteria, anti-amoebic approaches may represent a strategy in eradicating “superbugs” from the clinical setting in addition to the current measures.
This is a preview of subscription content, log in via an institution to check access.
References
Clinical and Laboratory Standards Institute (2010) Performance Standards for Antimicrobial Susceptibility Testing (CLSI). Twentieth Informational Supplement M100-S20. Wayne, PA, USA
Greub G, Raoult D (2004) Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 17:413–433
Ho PL, Chow KH, Yuen KY, Ng WS, Chau PY (1998) Comparison of a novel, inhibitor-potentiated disc-diffusion test with other methods for the detection of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Antimicrob Chemother 42:49–54
Jung S, Matin A, Kim KS, Khan NA (2007) The capsule plays an important role in Escherichia coli K1 interactions with Acanthamoeba. Int J Parasitol 37:417–423
Khan NA (2009) Acanthamoeba: biology and pathogenesis. Caister Academic, Norfolk. ISBN 978-1-904455-43-1
Khan NA, Jarroll EL, Paget TA (2001) Acanthamoeba can be differentiated clinically by the polymerase chain reaction and simple plating assays. Curr Microbiol 43:204–208
Khan NA, Siddiqui R, Elsheikha H (2010) Enemy within: strategies to kill “superbugs” in hospitals. Int J Antimicrob Agents 36:291
Kong HH, Chung DI (1996) PCR and RFLP variation of conserved region of small subunit ribosomal DNA among Acanthamoeba isolates assigned to either A. castellanii or A. polyphaga. Kor J Parasitol 34:127–134
La Scola B, Raoult D (2001) Survival of Coxiella burnetii within free-living amoeba Acanthamoeba castellanii. Clin Microbiol Infect 7:75–79
La Scola B, Audic S, Robert C, Jungang L, de Lamballerie X, Drancourt M, Birtles R, Claverie JM, Raoult D (2003) A giant virus in amoebae. Science 28:299
Marciano-Cabral F, Cabral G (2003) Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev 16:273–307
Salyers AA, Whitt DD (2002) Bacterial pathogenesis: a molecular approach, 2nd edn. ASM, Washington, D.C.. ISBN 155581171X
Acknowledgments
The authors are grateful for the kind support provided by The Aga Khan University, Pakistan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siddiqui, R., Sagheer, M. & Khan, N.A. Prevalence of Acanthamoeba and superbugs in a clinical setting: coincidence or hyperparasitism?. Parasitol Res 112, 1349–1351 (2013). https://doi.org/10.1007/s00436-012-3202-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-012-3202-5